SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-019881
Filing Date
2024-05-15
Accepted
2024-05-15 16:18:29
Documents
20
Period of Report
2024-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52678
2 ex1-1.htm EX-1.1 249986
3 ex5-1.htm EX-5.1 19966
4 ex99-1.htm EX-99.1 88137
5 ex5-1_001.jpg GRAPHIC 12382
6 ex5-1_002.jpg GRAPHIC 7457
7 ex99-1_001.jpg GRAPHIC 11318
  Complete submission text file 0001493152-24-019881.txt   703000

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE vbiv-20240509.xsd EX-101.SCH 3024
9 XBRL LABEL FILE vbiv-20240509_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE vbiv-20240509_pre.xml EX-101.PRE 22365
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3554
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 24951115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)